Bepirovirsen for renal insufficiency

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 1 trial. Early trial in people, checking safety. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 11 Sep 2025: Trial registered, NCT07168356
  2. 26 Sep 2025: Trial started, NCT07168356

The trials

NCT07168356: A Study to Evaluate Blood Levels of Bepirovirsen in Adult Participants With Severe or Moderate Kidney Disease

State
Under way
Phase
Phase 1
People
32 taking part
Started
26 Sep 2025
Primary completion
3 Mar 2026
Arms
Group 1- Severe Renal Impairment Participants, Group 2- Moderate Renal Impairment Participants, Group 3-Healthy Control Participants
Results
None posted
  1. 11 Sep 2025: Trial registered
  2. 26 Sep 2025: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 1 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.